A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer
Public ClinicalTrials.gov record NCT04746924. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind Study of Ociperlimab, an Anti-TIGIT Antibody, in Combination With Tislelizumab Compared to Pembrolizumab in Patients With Previously Untreated, PD-L1-Selected, and Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer
Study identification
- NCT ID
- NCT04746924
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- BeiGene
- Industry
- Enrollment
- 669 participants
Conditions and interventions
Conditions
Interventions
- Ociperlimab Drug
- Pembrolizumab Drug
- Placebo Drug
- Tislelizumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 23, 2021
- Primary completion
- May 29, 2025
- Completion
- Mar 17, 2026
- Last update posted
- May 11, 2026
2021 – 2026
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Providence Medical Foundation St Jude Heritage Healthcare | Fullerton | California | 92835 | — |
| Valkyrie Clinical Trials | Los Angeles | California | 90067 | — |
| Ocala Oncology Center Pl Dba Florida Cancer Affiliates Ocala | Ocala | Florida | 34474 | — |
| Advent Health Cancer Institute | Orlando | Florida | 32804 | — |
| Goshen Center For Cancer Care | Goshen | Indiana | 46526 | — |
| Baptist Health Lexington | Lexington | Kentucky | 40503 | — |
| University Medical Center New Orleans West Jefferson Medical Center | New Orleans | Louisiana | 70112 | — |
| Metro Minnesota Community Oncology Research Consortium (Mmcorc) | Saint Paul | Minnesota | 55101 | — |
| West Penn Hospital | Pittsburgh | Pennsylvania | 15224 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 209 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04746924, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 11, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04746924 live on ClinicalTrials.gov.